Preparation of Human Myocardial Tissue for Long-Term Cultivation
June 2nd, 2022
5.3K views
We present a protocol for ex vivo cultivation of human ventricular myocardial tissue. It allows for detailed analysis of contraction force and kinetics, as well as the application of pre- and afterload to mimic the in vivo physiological environment more closely.
Overview
This article presents a protocol for the ex vivo cultivation of human ventricular myocardial tissue, enabling detailed analysis of contraction force and kinetics. The method closely mimics the in vivo physiological environment through the application of pre- and afterload.
Key Study Components
Area of Science
- Cardiovascular Medicine
- Myocardial Physiology
- Ex Vivo Tissue Cultivation
Background
- Human left ventricular tissue slices can be cultivated ex vivo.
- A biomimetic chamber is used for cultivation.
- Pre and afterloads enhance physiological resemblance.
- This technique allows for continuous registration of tissue contraction.
Purpose of Study
- To assess vital contraction parameters in myocardial tissue.
- To facilitate screening for therapeutic and cardiotoxic drug effects.
- To improve understanding of myocardial function in a controlled environment.
Methods Used
- Submerging cultivation chambers and electrodes in a 10% isopropanol solution.
- Agitating the solution overnight for sterilization.
- Using user-defined stimulation protocols for contraction assessment.
- Long-term cultivation of myocardial slices in a biomimetic setup.
Main Results
- Assessment of post-pause potentiation and stimulation threshold.
- Evaluation of force-frequency relation and refractory period.
- Improved resemblance to in vivo conditions through pre and afterload application.
- Facilitation of future ex vivo research in cardiovascular medicine.
Conclusions
- The protocol enhances the study of myocardial contraction dynamics.
- It provides a valuable tool for drug effect screening.
- This method can lead to advancements in cardiovascular therapeutic strategies.
Frequently Asked Questions
What is the significance of using ex vivo myocardial tissue?
Ex vivo myocardial tissue allows for controlled studies of heart function and drug effects in a setting that closely mimics the physiological environment.
How does the application of pre and afterload affect the study?
Applying pre and afterload improves the physiological relevance of the contraction measurements, allowing for more accurate assessments of myocardial function.
What are some vital contraction parameters assessed in this study?
Parameters include post-pause potentiation, stimulation threshold, force-frequency relation, and refractory period.
What is the purpose of using a biomimetic chamber?
The biomimetic chamber provides an environment that closely resembles the conditions in the human body, enhancing the relevance of the findings.
How can this research impact cardiovascular medicine?
This research can lead to better understanding and screening of therapeutic and cardiotoxic effects of drugs, ultimately improving treatment strategies.
Executive Industry Relevance
Long-term ex vivo cultivation of human myocardial tissue slices enables direct functional assessment of cardiac contractility under near-physiological conditions. This platform supports predictive evaluation of pharmacological effects and mechanistic de-risking in early cardiovascular drug discovery. The approach enhances translational continuity by bridging in vitro findings with human tissue-level responses, informing portfolio decisions in preclinical R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of cardiac contractile mechanisms in human tissue context.
- Supports functional target validation by quantifying drug-induced changes in contraction parameters.
- Facilitates mechanistic de-risking for cardiovascular targets prior to in vivo studies.
Screening & Assay Development
- Provides a reproducible, biomimetic system for compound screening on human myocardial slices.
- Delivers quantitative outputs such as force-frequency relation and stimulation threshold for assay standardization.
- Allows real-time monitoring and recording of contractile responses to pharmacological agents.
Translational & Preclinical Research
- Aligns ex vivo functional data with disease-relevant human cardiac physiology.
- Enables assessment of therapeutic and cardiotoxic effects in a preclinical human tissue model.
- Supports risk-adjusted advancement decisions by providing predictive human data prior to animal studies.
Pipeline & Workflow Integration
This myocardial slice cultivation method integrates into the discovery-to-preclinical continuum, enabling early functional screening and mechanistic studies in human tissue prior to in vivo validation.
- Discovery Biology: Supports hypothesis testing of cardiac targets and pathways through direct contractility measurements.
- Screening: Offers assay-ready, reproducible human tissue slices for compound evaluation and dose-response analysis.
- Analytics: Provides quantitative readouts—post-pause potentiation, force-frequency relation, refractory period—for comparative analytics.
- Translational Research: Bridges in vitro and in vivo studies by modeling human cardiac responses to interventions.
- Enterprise Reuse: Establishes a reusable platform for ongoing cardiovascular drug screening and mechanistic research.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in cardiac drug discovery.
- Operational Value: Standardizes functional assays with reproducible, long-term tissue cultivation.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing early human tissue data.
- Portfolio Impact: Enables risk-adjusted prioritization of cardiovascular candidates based on human-relevant functional outcomes.
Implementation Considerations
- Requires expertise in myocardial tissue handling and ex vivo culture techniques.
- Needs specialized biomimetic cultivation chambers and real-time contractility measurement systems.
- Demands cross-team standardization of stimulation protocols and data analysis workflows.
- Adaptation may be needed for different cardiac regions or disease states.
- Careful tissue handling is critical to maintain viability and reproducibility, as supported by protocol details.
Biopharma FAQs
Why does null hypothesis testing matter for contraction parameter analysis?
Null hypothesis testing enables objective evaluation of whether observed changes in contraction parameters, such as force-frequency relation or post-pause potentiation, are statistically significant following pharmacological intervention. This supports robust target validation and reduces the risk of false positives in early discovery.
How does independent variable isolation fit myocardial slice drug screening?
By controlling stimulation protocols and pharmacological exposures in the ex vivo system, researchers can isolate the effects of specific compounds on myocardial contractility, clarifying mechanistic pathways and supporting confident lead identification.
What do quantitative dependent variable measurements enable in this workflow?
Quantitative measurements of contraction force, stimulation threshold, and refractory period provide actionable data for comparing compound effects, optimizing dosing, and informing go/no-go decisions in cardiovascular R&D pipelines.
Why are replication requirements critical for cross-functional cardiac studies?
Replication across multiple myocardial slices and experimental runs ensures reproducibility and reliability of contractility data, facilitating cross-team collaboration and enabling standardized comparisons in multi-site or multi-project settings.
Which statistical analysis capabilities are required before implementation?
Robust statistical tools are needed to analyze contractility outputs, assess significance of drug effects, and validate reproducibility, ensuring that functional findings can be confidently integrated into portfolio decision-making.
Chapters in this video
0:04
Introduction
1:01
Preparing Agarose and Vibratome
2:01
Trimming and Embedding the Samples
3:39
Placing the Samples on Cutting Tray and Setting Vibratome
4:17
Medium and Incubator Preparation During Slicing Procedure
5:07
Preparing and Mounting Slices
7:06
Changing Medium
7:51
Results: Ex Vivo Cultivation of Human Left Ventricular Myocardial Tissue for Detailed Analysis of Contraction Forces and Kinetics
10:15
Conclusion
